News
The selloff came after the U.S. Food and Drug Administration said late Friday that it was probing the death of an 8-year-old ...
The Food and Drug Administration’s polarizing vaccine chief is leaving the agency after a brief tenure that drew the ire of ...
-U.S. futures for the S&P 500 and Dow Jones Industrial Average rose 0.1% and Nasdaq futures gained 0.3%. Earnings will come today from Boeing, Spotify, United Health, Procter & Gamble, Visa and PayPal ...
The company can again ship the Duchenne gene therapy for patients who can still walk, following a one-week pause triggered by ...
F.D.A. resignation: The Food and Drug Administration’s top vaccine and gene therapy official resigned on Tuesday after a ...
3d
TipRanks on MSNSarepta price target raised to $5 from 0c at H.C. WainwrightH.C. Wainwright raised the firm’s price target on Sarepta (SRPT) to $5 from 0c and keeps a Sell rating on the shares after the FDA recommended ...
DIRECTING A CHANGING CDC — The Senate voted to confirm Susan Monarez as the next CDC director Tuesday, marking an end to the ...
Republicans are divided on the value of Ghislaine Maxwell as she takes center stage in the Jeffrey Epstein files saga. Some view the convicted sex trafficker as the key to unlocking additional ...
Investors braced for the Federal Reserve's next interest rate decision and earnings from tech giants Microsoft and Meta.
As director of the Center for Biologics Evaluation and Research, Dr. Vinay Prasad oversaw the regulation of vaccines and gene therapy drugs such as Sarepta Therapeutics' treatment for Duchenne ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results